The Right Dose - Metastatic Breast Cancer Trial Talk

Inside Clinical Trials

Personalized medicine is not just about what medication to choose, but also about how a medication is given to an individual patient. One important concept is “the right dose,” a personalized dose of medication adjusted according to the specific patient’s characteristics.

Currently, oncologists use either a flat dose (all patients receive the same dose) or a dose based on body surface-area for some cancer drugs like chemotherapies. However, studies have shown that using these approaches leaves some people underdosed and others overdosed, and this can lead to less effective treatment, drug resistance and increased side effects.

Giving the right dose–a personalized dose of medication–is important for maximizing effectiveness and minimizing toxicities.

Read the following articles to understand more about the “right dose” and how patients can get involved in advocating for their own “right dose.”


  • Drug Dosing Off Autopilot  Cancer Today presents the concerns of MBC patients and breast cancer oncologists about the current methods used to determine drug doses. 
  • Patient-Centered Dosing  Read or watch the presentation from advocate Anne Loeser and oncologist Dr. Aditya Bardia about how current oncology drug doses are determined, and why it’s important to use patient-centered dosing.  
  •  This nonprofit organization advocates Patient-Centered Dosing to help MBC patients achieve a better quality of life.

Last Modified on February 10, 2021



for past articles or specific information.